Biotheus Inc., a clinical-stage biotech company focused on the discovery and development of biologics for oncology and inflammatory diseases, announced that they have entered into a collaboration agreement with Hansoh Pharmaceuticals, for Biotheus'..
Biocon said on Tuesday that its Biocon Biologics subsidiary has secured all the regulatory approvals for the acquisition of Viatris' biosimilar business and is in the process of completing an $800 million equity infusion as part of the deal...
SK Biopharmaceuticals, a global innovative pharmaceutical company, announced that the state-run Korea Drug Development Fund (KDDF) has decided to support and finance the company's development of SKL27969, which is being evaluated as potential...
HitGen Inc. announced that it has entered into a research collaboration agreement with Daewoong Pharmaceutical Co., Ltd (“Daewoongâ€), a global healthcare group in the Republic of Korea, dedicated to improving the quality of patients' lives. HitGen...
Fujifilm India Pvt Ltd, a pioneer in diagnostic imaging and information systems for healthcare facilities has expanded its pulmonology solutions portfolio by launching a new slim video bronchoscope called EB-710P, which was unveiled at the National..
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide capsules, 25 mg and 50 mg...
AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC)...
Companies are now partnering with an expert turnkey provider can streamline their development processes without the burden of costs associated with in-house manufacturing. In this article, let's look into the key trends in pharma turnkey projects.
How pharmaceutical marketing enables Pharma companies to provide customized solutions and how the advanced pharma marketers are shifting to precision marketing which is related to targeting on digital platforms with custom messaging.
Biogen Inc tapped former Sanofi boss Christopher Viehbacher as its new chief executive, betting on an industry veteran to help the U.S. drugmaker put behind it a series of setbacks for Alzheimer's drug Aduhelm...
, CDSCO.jpg)
